Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ENANTA PHARMACEUTICALS INC | Chief Legal Officer | Common Stock | 75.7K | $680K | $8.99 | Feb 26, 2024 | Direct |
ENANTA PHARMACEUTICALS INC | Chief Legal Officer | Common Stock | 35.9K | $323K | $8.99 | Feb 26, 2024 | By grantor retained annuity trust |
ENANTA PHARMACEUTICALS INC | Chief Legal Officer | Stock Option (Right to Buy) | 77.8K | Feb 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENTA | ENANTA PHARMACEUTICALS INC | Feb 26, 2024 | 2 | $46.6K | 4 | Feb 27, 2024 | Chief Legal Officer |
ENTA | ENANTA PHARMACEUTICALS INC | Feb 12, 2024 | 2 | -$12.1K | 4 | Feb 14, 2024 | Chief Legal Officer |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 5, 2023 | 1 | -$23.2K | 4 | Dec 6, 2023 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2023 | 1 | -$15.1K | 4 | Dec 5, 2023 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Nov 22, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Apr 18, 2023 | 2 | $200K | 4 | Apr 19, 2023 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Feb 13, 2023 | 3 | -$355K | 4 | Feb 15, 2023 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2022 | 1 | -$46.8K | 4 | Dec 5, 2022 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Nov 23, 2022 | 2 | $0 | 4 | Nov 28, 2022 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Feb 14, 2022 | 3 | -$59.8K | 4 | Feb 15, 2022 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2021 | 1 | -$48.8K | 4 | Dec 3, 2021 | Sr. VP & General Counsel |
ENTA | ENANTA PHARMACEUTICALS INC | Nov 19, 2021 | 2 | $0 | 4 | Nov 23, 2021 | Sr. VP & General Counsel |